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Simple assessment of the efficacy of peritoneal transport In continuous
ambulatory peritoneal dialysis (CAPD) patients. KREDIET RT,
BOESCHOTEN EW, ZUYDERHOUDT FMJ, and APsz L. Renal Unit,
Academic Medical Centre, Amsterdam, The Netherlands. Mass trans-
fer area coefficients (MTC) of urea, lactate, creatinine, glucose, intra-
peritoneally (i.p.) administered kanamycin and inulin were determined
on 13 occasions in 11 stable CAPD patients using the "Garred" model
(a relatively simple model assuming first order kinetics). Simulta-
neously i.p. volume was measured with autologous hemoglobin. During
a four-hour dwell of Dianeal®, 1.36% 10 dialysate and two blood
samples were taken. The i.p. volume increased during the first hour,
followed by a plateau phase and a gradual decrease, especially during
the last hour. The mean difference between maximal and initial volume
was 11%, residual volume was 394 mliter and hemoglobin recovery
92%. The 95% confidence limits (maximum: r = 1.00) of the MTC's
varied between 0.96 and 1.00, indicating the correctness of the model
when multiple dialysate sampling was used (MTCmS). As volume
changes were only modest, a further simplification was tested using the
dialysate solute concentration before installation in the peritoneal
cavity and the concentration at the end of the study, while mean i.p.
volume was assumed to equal the drainage volume. This resulted in the
following equation: MTCZCS (zero— and end sample) = Vend t [lnV0(P — D0) — inVend (P—D erni)] in which V = volume, D = dialysate
concentration and P = plasma concentration. Mean values were:
MTCmsN (mliter/min) MTCZCS r
urea 13 21 21 0.94
lactate 12 17 16 0.80
creatinine 13 10 10 0.95
glucose 13 10 10 0.89
kanamycin 10 9 9 0.95
inulin 12 4 5 0.86
In conclusion, for the follow—up of CAPD patients a simple and yet
correct assessment of the efficacy of peritoneal transport can be
obtained by the use of only two dialysate and blood samples.
Treatment of post transplant hyperparathyroldism with APD: a new
biophosphonate. LEUNISSEN KML, VANLEENDERTR, VISMANS F, and
VAN HOOF JP. Department of Internal Medicine, St. Annadal Hospital,
6201 BX, Maastricht, The Netherlands. Severe post transplant hyper-
parathyroidism is treated always surgically by almost complete removal
of the parathyroid glands. We want to report the medical treatment of
post transplant hyperparathyroidism with APD (3-amino—l-
hydroxy.-propylidene 1. 1—diphosphonate) in two patients. Both patients
had severe bone pain, elevated serum calcium levels and increasing
parathyroid hormone (PTH 1-84) levels one year after a successful renal
transplantation (Table 1). Vitamin D levels were normal. The bone
biopsies and bone scintigraphies were compatible with hyperpara-
thyroidism. During treatment with APD 150 mg rid, complaints disap-
peared within one week; serum calcium leveJs gradually decreased to
near normal levels. Parathyroid hormone level decreased as well as the
urinary hydroxyproline excretion (Table 1). Bone biopsies three months
after starting therapy showed no further progress of the renal osteodys-
trophy, as compared to the biopsies before treatment. There were no
adverse reactions to APD.
Table 1.
Patient 1 (Cyclosporin) Patient 2 (Cyclosporin)
After 12 After 12
Baseline weeks Baseline weeks
SEM treatment SEM treatment
Clearance,
mliter/min 45 45 50 50
Calcium,
mmole/liter 2.95 0.05 2.62 2.93 0.05 2.70
n: 2.10—2.65
Parathyroid hor-
mone, pmole/
liter 5.61 2.00 1.56 0.92
Ca t:
(N < 0.75)
Urinary hydroxy-
proline excre-
tion, mole/
mmole creatinine 62 22 47 19
Recently a third patient with persistent post transplant hyperpara-
thyroidism was treated with APD. The same pattern as in the two
patients above was observed: a decrease in serum calcium level and a
60% decrease of the PTH level after one month of treatment. In
summary, the effects of the diphosphonate APD in two patients with
persistent post transplant hyperparathyroidism are described. The
following observations were made: complete disappearance of bone
pain within one week, a gradual decrease of serum calcium to near
normal levels and a decrease of PTH release.
Influence of urinary flow rate on protein excretion in patients with renal
disease. WETZELS JFM, HOITSMA AJ, HUYSMANS FTHM, and KOENE
RAP. Department of Medicine, Division of Nephrology, St. Radboud
Hospital, University of Njjmegen, Njmegen, The Netherlands. We
studied the influence of urinary flow rate on urinary protein excretion
rate in nine patients with renal disease and proteinuria of over 1.5 g/24
hr. In all patients creatinine excretion rates were measured simulta-
neously. Our results show a definite influence of urinary flow rate on
protein excretion. At flow rates below 1.0 mliter/min there was a highly
significant positive correlation between flow rate and proteinuria. When
the urinary flow rate decreased from 1.0 to 0.5 mliter/min, protein
excretion was reduced by 30 to 50%. The flow dependent character of
protein excretion disappeared at flow rates above 1.0 muter/mm.
Creatinine excretion was also influenced by urinary flow rate. In one
patient we studied glomerular filtration rate using inulin clearances. In
this patient, changes in urinary flow rate, in protein excretion, and
creatinine excretion were not accompanied by changes in glomerular
filtration rate. Changes in proximal tubular reabsorption must be
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responsible for the effects observed. In measuring protein and creati-
nine excretion rates, urinary flow rate should be accounted for.
Circadian variations in urinary excretion of serum proteins in patients
with a nephrotic syndrome. KOOPMAN MG, KREDIFT RT,
ZUYDERHOUDT FMJ, DE MOOR PAM, and ARIsz L. Academic Medical
Centre, Amsterdam, The Netherlands. We studied circadian variations
in urinary excretion of various serum proteins during three successive
days in 24 patients with a nephrotic syndrome. The patients were
studied under a regimen of bedrest and identical meals every three hr.
Urine samples were collected per three hr. For comparison of the
results a computer program was developed to calculate the best fitting
sinusoidal graph. The relative amplitude (AIM x 100%) and the phase of
the rhythm were deduced from the fitted graph. In 17 of 24 patients
(7 1%) the urinary excretion of albumin, transferrin and IgG was higher
during the day than during the night, with a maximum around 16.30 hr
and a minimum around 4.00 hr. The mean AIM of the rhythms of IgO
excretion (77%) was significantly higher than the mean AIM of the
rhythms of albumin (54%) and transferrin excretion (55%). Serum
concentrations of the proteins were not different between day and night
samples. A large interindividual variation in phase and AIM was
observed. In 11 of the 13 patients who had a higher AiM of their IgG
rhythm than of their albumin and transferrin rhythm, a circadian rhythm
of the selectivity index (clearances of IgGltransferrin) of proteinuria
was seen with the lowest index at night. Circadian variations in urinary
excretion of beta-2-microglobulin were studied in 20 patients. Twelve of
them (60%) excreted more beta-2-microglobulin during the day than
during the night with a maximum around 15.00 hr and a minimum
around 4.00 hr; the mean AIM was 63%. In individual patients an
albumin rhythm could be present while a beta-2-microglobulin rhythm
was absent and the other way around. We conclude that most patients
with a nephrotic syndrome excrete serum proteins in the urine in a
circadian pattern. In several patients, the circadian variability in the
excretion of the larger IgG molecule was more pronounced than that of
the other proteins, resulting in a rhythm of the selectivity index. The
relationship between the circadian variations in beta-2-microglobulin
excretion and albumin excretion was variable in individual patients.
Effect of indomethacin (I) on the protein—induced glomerular
hyperfiltration in man. VANRENTERGIJEM Y, VERBERCKMOES R, ROELS
L, and MICHIELSEN P. Department of Pathophysiology, Division of
Nephrology, U.Z. K. U. Leuven, B-3000 Leuven, Belgium. The mech-
anisms governing the renal hyperemia and glomerular hyperfiltration
induced by protein loading remain unresolved. The present study in
nine healthy volunteers examines the possible role of prostaglandins as
mediators of the acute protein—induced glomerular hyperfiltration.
After hydration (diuresis 10 to 15 mliterlmin) endogenous creatinine
clearances (C1) and inuline clearances (C11,.) were measured: three and
six consecutive 30 mm urine collections were obtalned before (basal)
and after oral intake of 80 to 90 g protein (test), respectively. The same
study was repeated after ten days of 1(150 mglday). On the morning of
the study, 50 mg of I was given orally 4 hr before the start of the first
basal urine collection, and repeated at the time of the protein intake.
Results are given as mean values 5D (mliterlmin).
Control Indomethacin
N Basal Test Basal Test
Ccr 9 143±15 163±19* 152±19 167±18*
C1 9 117±12 131±17* 124±13 134±18*
* basal versus test P C 0.01 (paired t-test).
The procentual increase of Ccr after protein loading was 14 8%
without, and 10 6% with I (difference not significant). For C1,,, the
increase was 12 5% without and 8 4% with I (P C 0.01). The
present study demonstrates that I has no major influence on the
glomerular hyperfiltration induced by an acute oral protein load.
Influenza vaccination in hemodialysis and renal transplant patients.
VERSLUIS DJ, BEIJER WEP, MASUREL N, and WEIMAR W. Depart-
ments of Internal Medicine I and Virology, University Hospital,
Rotterdam—Djjkzigt, Rotterdam, The Netherlands. Influenza virus in-
fection leads to a high incidence of morbidity and mortality in high risk
patient groups. Therefore influenza vaccination has been recommended
for organ transplant recipients. However, different immune regimens
may result in ineffective antibody responses after vaccination. We
studied the effect of an inactivated influenza vaccine [AIPhilippineI2I82
(H3N2), AIChileIlI83 (H1N1) and BIUSSRJIOOI83 (B)] in renal transplant
recipients with life—sustaining kidney function, and compared the
results of vaccination in 21 patients on cyclosporine A (CsA) with 38
patients on azathioprine (AZA). Both patient groups received low dose
prednisone. Twenty—nine healthy volunteers and 28 patients on
hemodialysis (HD) served as controls. In 103 of 116 individuals, a
booster immunization was performed on day 30. Efficacy of vaccination
was determined by antibody levels (hemaglutination—inhibition test),
percentage of subjects showing fourfold titer rises, achievement of
protecting titers (H3N2 + H1N1 > 100, B > 50) and results of booster
immunization. No statistical difference in antibody response against the
three viruses was observed between patients on AZA and healthy
controls. However, CsA treated patients showed significantly (P C
0.05) lower antibody responscs against Influenza A viruses than pa-
tients on AZA or healthy controls, whether geometric mean titers,
fourfold titer rises, or conversion rate to protecting titers were
analysed. Patients on HD also had impaired humoral immune responses
to vaccination compared to healthy controls. In renal transplant recip-
ients not responding with protecting titers to primovaccination, booster
immunization resulted in protecting titers in 2 out of 11 H3N2, zero out
of 10 H1N1, and 3 out of 36 B patients. We conclude that CsA, in
contrast to AZA, impairs humoral immune responses. Booster immu-
nizations proved of moderate value in renal transplant recipients.
Cadaveric renal transplantation (CRT) without previous chronic dial-
ysis treatment as an alternative approach in the treatment of end stage
renal disease. TEGZESS AM, MEIJER 5, VAN SON WJ, VAN DER WOuDE
FJ, SLOOFF MJH, SLUITER V/f, and DONKER AJM. Renal Transplant
Service, University Hospital, Groningen, The Netherlands. We decided
to perform CRT without previous chronic dialysis, because of the
following reasons: 1) to shorten the period of renal insufficiency; 2) to
increase the efficient use of donor kidneys harvested by our transplant
service; 3) to help patients with a chronic rejection who prefer not to be
dialysed again; and 4) to relieve our dialysis units. Thirty patients with
a follow—up period of three months to five years (median two years)
were treated in this way (group 1). As a control population, we matched
every patient from group 1 with the nearest cadaveric kidney recipient
in time who was on chronic dialysis treatment before transplantation
(group 2). Both groups were comparable as to the cause of renal fallure,
sex, immunosuppression, preoperative plasma protein and hemoglobin
concentrations, and the frequency of a short preoperative dialysis
because of a high serum potassium level. The median creatinine
clearance in group 1 amounted to nine mliterlmin (range 5 to 27), The
median time on dialysis in group 2 was 21 months (range 3 to 120). The
median age of group 1 was higher than of group 2: 43 and 32 years,
respectively; P C 0.05. In both groups two cases of mortality were
observed. The graft survival at three months was 25 out of 30 (83%) in
group 1 and 23 out of 30 (76%) in group 2. Patients in group 1 had a
shorter median hospitalization time, 30 vs. 49 days, P C 0.03, and a
higher median creatinine clearance after three months, 59 vs. 48
mliterlmin., P C 0.05. As expected, more patients in group 2 needed
postoperative hemodialysis (18 vs. 7 patients, respectively; P C 0.01).
After graft failure all native kidneys were functioning with identical
creatinine clearances as before CRT. Our results suggest that CRT in
patients with preterminal renal failure is at least as safe and successful
as CRT in patients on chronic dialysis. Furthermore, it leads to an
earlier revalidation of the patients, saves the costs of dialysis treatment,
and appears to shorten the hospitalization time after CRT.
The impact of age of the donor on the renal graft survival. HOITSMA
AJ, WETZELS JFM, and KOENE RAP. Division of Nephrology, Univer-
sity of Njjmegen, N(jmegen, The Netherlands. It has been suggested
that kidneys from young donors do less well after transplantation. We
have studied this problem in a retrospective analysis of all cadaveric
transplants performed in our center during the last 10 years. All patients
were followed for at least three months. Recipients younger than 16
years were excluded from this analysis. Thirty—six patients received a
kidney from a donor younger than 10 years (Group 1), 362 received a
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kidney from a donor aged between 10 and 51 years (Group 2), and 20 a
kidney from a donor older than 51 years (Group 3). There were no
significant differences in risk factors between the three groups. The
graft survival in Group 1 was significantly worse than in Groups 2 or 3
(three months graft survival was respectively 61%, 83%, 81%, and one
year graft survival was respectively 44%, 75%, 63%). A possible
explanation for these worse results could be a higher incidence of
technical problems in the young donor group. Indeed there were
significantly more technical failures in Group 1, but if these were
excluded a significant difference in graft survival remained present. At
three months there were no differences in hypertension, proteinuria, or
serum creatinine between the three groups. We conclude that the
decreased survival of kidneys from young donors is only partly caused
by technical problems. These grafts seem to be also more susceptible to
the hosts' immune response.
Use of blood from arterial lines for gas analysis in hemodialysis.
SCHUURMANS MMJ and Go IH. Canisius—Wilhelmina Hospital,
Nmegen, The Netherlands. Arterial blood for blood gas analysis
usually is drawn from the arterial line. However, the high blood flows
used with modern dialysis techniques may lead to considerable
veno—arterial recirculation. This will cause spuriously low pCO2 levels
in the arterial line during acetate dialysis, or spuriously high levels
during bicarbonate dialysis, In 10 patients with an arteriovenous fistula
we found an average recirculation of 12% (urea dilution technique). In
the venous line, the maximal decreases of pCO2 were as high as 40 mm
Hg in acetate dialysis, whereas increases of 45 mm Hg were seen in
bicarbonate dialysis. This led to a difference between pCO2 of arterial
blood as compared to that of the arterial line up to 5 mm Hg at 12%
recirculation. No significant difference in PO2 was found. With a
simulated recirculation in vitro, we found that the true arterial pCO2
could be approached by the equation: pCO2(a) = r x pCO2(v) + (1 — r)
X pCO2(art); where r, fractional recirculation; v, venous line; a, arterial
line; art, true arterial value. In the samples from 10 dialysis patients,
there was a close correlation of the calculated and observed differences
in pCO2 between arterial blood and blood from the arterial line (r =
0.97). Thus in the event of recirculation, introduction of this value(pCO2 measured in the arterial line blood) into the alveolar gas
equation, will produce an error in (A-a)D02. The formula mentioned
above can correct for this error.
Effect of verapamll and atriopeptin Ill on renal function after renal
ischemia. MATTHYS E and LAMEIRE N. Renal Division, University
Hospital, Gent, Belgium. The effect on renal function of two different
renal vasodilating and natriuretic agents, i.e. verapamil (V) and a
synthetic atriopeptin III (AP111) was investigated in the rat 24 hr after
unilateral clamping of the renal artery during 40 mm. Both V and AP111
were intravenously infused from 10 mm before clamping to 45 mm after
restoration of renal blood flow (RBF). Whereas in the control clamped,
unpretreated rats, all kidneys were anuric after 24 hr, GFR after V and
24 hr post-ischemia (N = 13) was 0.12 0.05 mliter/min (P < 0.01).
After AP1, all kidneys (N = 7) remained anuric. Preliminary results
indicate that RBF, measured by electromagnetic flowmeter, was re-
stored to 64% of the control value 45 mm after release of the clamp in
both control and AP111 pretreated rats. This was similar to the values
obtained with V. Renal histology, however, was qualitatively not
different between verapamil—protected and control kidneys. It is con-
cluded that although renal reflow is similar in V and AP pretreated
rats, V seems to offer a moderate protection of renal function after
ischemic insult, independent of its renal hemodynamic and natriuretic
effects.
Clinical aspects of long—term use of magnesium hydroxide (Mg(OH)2)
as alternative phosphate (P) binder in patients on maintenance
hemodialysis. OE PL, VAN DER MEULEN J, Lips PTAM, DE VRIES
PMJM, VAN DER MEER J, and DONKER AJM. Department of Medicine,
Academic Hospital Free University, Amsterdam, The Netherlands.
The long—term use of Mg(OH)2 as phosphate binder was investigated in
18 patients on chronic hemodialysis in a three-period study. At the start
of the study, each patient ingested aluminum hydroxide (Al(OH)3) only
(period 1). Thereafter, Mg(OH)2 was used for four months (period 2)
and finally Al(OH)3 was added for 10 months (period 3). During periods
2 and 3 a dialysate devoid of magnesium (Mg) was used. The mean dose
of Mg(OH)2 in period 2 was 2.4 0.6, in period 3 2.6 1.2 glday. In the
14 patients completing the study, no Mg toxicity was observed. In
seven patients troublesome diarrhea was a limiting factor for increasing
Mg(OH)2 dose, while in the remaining seven patients the limiting factor
was severe hypermagnesemia (serum Mg> 2.3 mmole/liter). Serum P
concentration increased from 1.42 0.24 to 2.01 0.49 mmole/liter (P
<0.005) after substituting Mg(OH)2 for Al(OH)3. After the addition of
Al(OH)3 to Mg(OH)2 in period 3, serum P concentration fell again to
1.63 0.21 mmole/liter (P < 0.005). Despite a halving of the Al(OH)3
dose from 6.6 2.3 glday in period ito 3.3 1.4 g/day in period 3,
serum aluminum (Al) level in period 3 was the same as in period 1(55.8
19.1 vs. 57.1 27.3 gfliter). Therefore, the ratio between serum Al
and daily consumption of Al(OH)3 increased from 9.8 4.6 in period 1
to 17.8 10.2 in period 3 (P < 0.005). Parathyroid hormone concen-
tration decreased from 26.6 21.8 pmole/liter in period 1 to 18.6 20.6
pmole/liter in period 2 (P < 0.005). In period 3 a further decrease to 7.8
6.0 pmole/liter (P < 0.005) occurred. Serum potassium concentration
increased from 5.1 0.4 mmole/liter in period ito 5.7 0.3 mmole/liter
in period 2 (P < 0.005) and decreased to 5.5 0.4 mmole/liter in period
3 (P < 0.005), although the latter value was still higher than in period I
(P < 0.01). We conclude that long—term use of Mg(OH)2 as phosphate
binder was not hazardous, provided serum Mg concentration was
carefully monitored. Although in combination with Al(OH)3 the sub-
stance may halve the necessary amount of Al(OH)3, the serum Al level
is not lowered due to increased absorption of Al from the gut. Another
aspect is that oral Mg(OH)2 may increase serum potassium. However,
the observed suppression of parathyroid activity during Mg(OH)2
administration may be of clinical importance and warrants further
study.
Renal transplantation in light chain nephropathy. GERLAG PGG,
KOENE RAP, and BERDEN JHM. St. Joseph Hospital, Eindhoven, Si.
Radboud Hospital, University of Nmegen, The Netherlands. A
40—year—old male patient with monoclonal gammopathy developed
irreversible renal insufficiency caused by kappa light chain deposition in
the kidney. His disease was further characterized by extensive tissue
deposition of light chains (skin, liver, bone) and by marked orthostatic
hypotension. A bone marrow aspirate showed a plasmocytosis of 11%.
Treatment with melphalan and prednisone resulted in a remission, with
normalization of the bone marrow, disappearance of tissue deposits,
and of the orthostatic hypotension. After 4.5 years of chronic intermit-
tent hemodialysis treatment, a cadaveric kidney transplantation was
performed, resulting so far in excellent renal function (3.5 years after
transplantation). Renal failure in these patients seems to be caused by
the noxious effects of the tumour product and does not reflect the
severity of the disease. The response rate to chemotherapy, the
duration of remission, and the prognosis are similar to those of patients
without uremia. Therefore, there is no good reason to exclude them
from renal replacement therapy. Along with eight previously reported
patients, this case demonstrates that even transplantation can be
offered to these patients, once they are in remission and no other major
complications of their monoclonal gammopathy are present. However,
because of the evident risk of recurrence of the disease, cadaveric and
not living related donor kidneys should be used primarily in these
recipients.
Pseudohypoaldosteronism: studies in three infants. SCHRODER C,
MONNENS L, and LiMBowo G. Department of Pediatrics, University of
Nmegen, The Netherlands. Three infants with pseudohypoaldosteron-
ism, in which unresponsiveness to mineralocorticoids have been dem-
onstrated in the kidney, could be studied during the first month of life.
This disease was not yet observed in the Netherlands. In two infants,
severe neonatal hyponatremia and hyperkalemia (11 to 12 mEq/liter)
was observed. Both also had lasting salivary and sweat sodium loss.
Both were initially treated by peritoneal dialysis. The third infant had a
milder course and required only 1.5 g additional natriumchloride. The
clinical course of the two infants with the severe form could easily be
confused with septicemia and shock during the neonatal period. Earlier
studies indicated the proximal tubule as the site of sodium loss. The
renal handling of water and sodium was studied using clearance
methods during hypotonic saline diuresis. In the two infants with the
fulmmnant course, the proportion of the "normal" distal sodium load
reabsorbed distally was clearly diminished. No significant differences
944 Abstracts
were observed in the infant with the milder course. The two infants with
the severe form were unable to tolerate the large amount of
natriumchloride without indomethacin therapy. Indomethacin adminis-
tration decreased the amount of required natriumchloride supplemen-
tation. A slight increase in serum potassium was noted. Indomethacin
by reducing the amount of sodium in the distal tubule could be
dangerous in these children with an already high serum potassium
concentration. It should be given in combination with ion—exchange
resin.
Acetate versus bicarbonate dialysis in ventilated patients. VAN GEELEN
fA, WOITTIEZ AJf, WENTING Gf, and SCHALEKAMP MADH. Depart-
ment of Internal Medicine I, University Hospital Rotterdam—D(jkzigt,
Rotterdam, The Netherlands. Dialysis treatment of acute renal failure
in critically ill patients is ofteo associated with unstable blood pressure
behaviour. The occurrence of hypoxemia and inadequate correction of
acidosis may be involved in the pathogenesis. Improved treatment
tolerance has been reported after the introduction of bicarbonate
containing dialysate. In the present study, the influence of mechanical
ventilation was studied during acetate and bicarbonate dialysis in seven
critically ill patients suffering from septicemia and circulatory failure.
All patients were ventilated by a standard mechanical ventilator and
five patients received vasopressor drugs throughout the study period.
Four hours recirculating acetate and bicarbonate dialysis treatments
were performed in random order. Only AN-69 membranes were used.
During the treatment blood pressure was measured intraarterially and
samples were taken for blood gas analysis and determination of
acid—base balance and electrolyte concentrations, Seven non-ventilated
patients, treated by the same dialysis regimen, served as controls. In
the ventilated patients no significant differences were observed between
acetate and bicarbonate dialysis with regard to blood pressure
behaviour, heart rate, and arterial oxygen tension at comparable rates
of fluid removal during both dialysis treatments. Correction of acidosis
was adequate iu both treatments although bicarbonate levels were
higher after bicarbonate dialysis (26.6 mmole/liter) than after acetate
dialysis (23.8 mmole/liter). During acetate dialysis, hypoxemia did not
occur in the ventilated patients, whereas in non-ventilated patients
arterial oxygen tension decreased from 11.3 to 8.4 kPa. Also, non-
ventilated patients demonstrated a significant decrease in arterial blood
pressure during acetate dialysis in contrast to bicarbonate dialysis. The
conclusion was reached that non-ventilated critically ill patients benefit
from bicarbonate dialysis. However, in ventilated patients there seems
to be no reason to give preference to bicarbonate dialysis over acetate
dialysis, and the prevention of hypoxemia may be a key factor in blood
pressure control.
Mononuclear subsets monitoring during CMV infection In renal trans-
plant recipients on cyclosporine A. METSELAAR Hf, RazING J, VAESSEN
LMB, ROTIIRARTIt PnH, JEEKEL J, and WEIMAR W. Departments of
General Surgery, Virology and Internal Medicine!, University Hospital
Rotterdam—Djjkzigt, Rotterdam, The Netherlands. In renal transplant
recipients, cytomegalovirus (CMV) infection may result in a clear
clinical syndrome. However, in some patients differentiation with
rejection or other infections can be difficult. Since virological confir-
mation of overt CMV may take several weeks, there is a need for
additional diagnostic tools. T-lymphocyte subsets in conventionally
treated renal transplant recipients may show an inversion of the ratio
during CMV infection, hut in patients on cyclosporine (CsA), this
phenomenon is thought to be less evident. We studied the incidence of
clinical symptomatic CMV disease and concomitant variations in cir-
culating mononuclear cells in 49 renal transplant recipients. Mononu-
clear subsets monitoring was done with monoclonal antibodies of the
Leu—series. Patients were treated with cyclosporine, low dose predni-
sone and in case of biopsy proven rejection with rahbit—antithymocyte
globulin (RATO). Clinical overt CMV disease (fever, leuco— or
thrombocytopenia, hepatitis, fourfold IgG antibody titer rise andlor
isolation of the virus) was diagnosed in eight patients. All had been
treated with RATG, while none of the non-rejecting patients suffered
from CMV disease. In all studied patients with CMV, a true inversion
of T helper/T suppressor—cytotoxic ratio was found with a significant
rise of the Leu—2a positive celis (T suppressor—cytotoxic) and a
reduction of the T-3a positive cells (T helper). The fail in Th)Ts-c ratio
heralded the onset of the first symptom by one week. Rejection was not
associated with an inverted ratio (median 2.2 range 0.6—4.7). In only two
other patients an inversion of Th/Ts-c ratio was found. These patients
proved to have another viral disease, No significant changes were seen
in the percentages of Leu-7 (NK cells), Leu-12 (B cells) or DR
expression. This study shows that monitoring T cell subsets can be
useful in diagnosing viral infection in patients treated with cyclosporine.
Furthermore inverted ratios can discriminate between rejection and
viral infection.
Renal response to converting enzyme blockade. DE LEEUW PW, VAN
Es PN, LOOMAN JHM, and BIRKENHAGER WH. Department of Medi-
cine, Zuiderziekenhuis, Rotterdam, The Netherlands. To investigate
the renal actions of the converting enzyme inhibitor enalaprilie acid, we
infused incremental doses of this drug into the renal artery of hyper-
tensive patients just prior to renal angiography. One group (N = 6)
received doses of 0.1, 0.3, and 1 sg/kg.min, while in another group (N
7) doses of 1, 3 and 10 jzg/kg.min were given. Each dose was infused
for 10 mm, at the end of which renal blood flow was assessed by means
of xenon—washout. At the same time, blood was sampled from the renal
artery and vein for determination of converting enzyme, renin and
angiotensin II. Enalaprilic acid caused a dose—related suppression of
converting enzyme activity, which was maximal at a dose of I
,ag/kg.min; arterial levels fell more steeply than venous ones. Angio-
tensin II disappeared in parallel with the drop in converting enzyme.
Renal blood flow, on the other hand, began to increase only when 3
.tgIkg.min was given and no further changes occurred with the highest
dose. Intra-arterial blood pressure fell only when the highest dose was
given. Renin secretion tended to increase, but changes were not
statistically significant. It is concluded that systemic suppression of
converting enzyme is needed for renal vasodilation to occur. However,
the renal vascular response comes wetl before blood pressure falls.
Cell culture and characterization of human mesangial cells in vitro.
MULLER EW, VAN DER WOUDE FJ, GROND AJK, DONKER AJM, and
VAN DER HEM GK. Departments of Internal Medicine, University
Hospital Groningen and University Hospital of the Free University
Amsterdam, The Netherlands. Cell culture of isolated human glomer-
ular cells could he an important tool in the study of renal disease.
Although there is now considerable agreement on the culture and
characteristics of rat glomerular epithelial and mesangial cells in vitro,
the isolation and characterization of human glomerular cells in vitro is
still controversial. We have developed a technique for growing human
mesangial cells in vitro by selectively subculturing of primary out-
growths from glomerular explants. Whole glomeruli were obtained by
graded sieving of dissociated kidney cortex from normal adult human
kidney tissue. After three to five weeks of primary culture giving rise to
the spreading of glomerular epithelial cells (GEC), a distinct population
of cells was observed to grow out from the attached glomeruli, growing
in an overlapping fashion over the established epithelial cell monolayer.
These cells could be scraped off the culture flask and subcultured
subsequently. By light microscopy they appear to be large and stellate
cells, assuming a more spindle shape morphology on reaching confiu-
ency. Then, they also organize in a hill—and—valley growth pattern, as
seen with smooth muscle cells in vitro. By histochemical staining
techniques they appear not to contain keratin filaments, present in GEC
in vitro, nor desmin filaments, present in vascular smooth muscle cells.
Fibriular positive staining was obtained using an antiserum against
myosin. Also, positive staining with MBM 10, a monoclonal antibody
against mesangial matrix components (kindly provided by Dr. A. F.
Michael, Minneapolis, USA) was observed with extracellular matrix,
produced in vitro hy these cells, not by GEC. Furthermore, they were
phagocytic for fixed human erythrocytes, and show a contractile
response upon incubation with isoproterenol (l04M) and theophyllin(l02M), as described for rat mesangial cells in vitro. We believe we
have sufficient proof for the identification of these cells as derived from
the glomerular mesangium.
LILA-DR antigens on peripheral blood lymphocytes and in graft
tubular epithellal cells in association with renal allograft rejection.
HENNY PC, WEENING ff, TANKE Hf, and PAUL LC. Departments of
Nephrology, Pathology and Histochemistry and Cytochemistry, Uni-
versity Hospital, Leiden, The Netherlands. To investigate whether
HLA-DR expression of peripheral blood T lymphocytes is of help in the
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diagnosis of rejection, the lymphocytes of 84 renal transplant patients
were monitored by flow cytometry during the first three months after
transplantation (41 patients were treated with cyclosporin A (CsA) and
43 with azathioprine (Aza)). Frozen sections of 50 renal biopsies
obtained from 43 patients (21 CsA— and 22 Aza—treated) were stained
for HLA-DR using an indirect immunoperoxidase technique. Retro-
spective analysis showed a correlation (P < 0.0005) between the
presence of a subset of strongly HLA-DR--expressing lymphocytes in
peripheral blood and the occurrence of a rejection episode in the Aza
treated patient group. Twenty—three of the 25 patients who developed
1% DR cells received an anti-rejection treatment within 10 days of this
observation, whereas six patients received anti-rejection therapy with-
out a measurable preceding DR expression (< 1%). Since only five of 20
CsA—treated patients with 1% DR peripheral lymphocytes received
an anti-rejection treatment, whereas eight patients were treated for a
rejection without an increased DR expression, no correlation was found
in the CsA—treated group. DR—expression of renal tubular cells corre-
lated with the diagnosis of rejection in both groups. In addition, in both
treatment groups the presence of strongly DR—expressing lymphocytes
in peripheral blood correlated with a positive staining for HLA-DR of
the renal tubular cells (p <0.001). These findings support the possibility
that the expression of HLA-DR on renal tubular cells may be induced
by activated I lymphocytes. Since the HLA-DR staining on either
circulating T cells or renal tubular cells appears to be associated with
rejection in the Aza—treated group, these parameters may also be of
help in the differentiation of deterioration of graft function in
CsA—treated patients.
Acute glomerulonephrltis in the rat induced by a single intravenous
injection of monoclonal anti-rat—thymocyte antibodies. BAGCHUS WM,
R0ZING J, HOEDEMAEKER PiiJ, and BAKKFR WW. Departments of
Pathology, Groningen and Leiden; Department of Internal Medicine,
Rotterdam, The Netherlands. Rabbit antibodies against rat thymocytes
(ARTS) are nephritogenic in that they are able to bind to rat glomeruli
in vitro and in vivo. However, it is not clear whether experimental
nephropathy induced by ARTS in the rat is a result of shared epitopes
upon thymocytes and glomeruli, or is due to contaminating antibodies.
Therefore, we used (mouse) monoclonal anti-thymocyte antibodies
(MoAbs) of the IgG2a (ER4) or IgGl (ER 14) subclass, respectively, for
the induction of glomerulonephritis in two—months—old female Wistar
rats. Each rat received a single intravenous injection of 400 g lgG in
0.5 mliter saline per 100 g bodyweight of either ER4 (N = 7)or ER14 (N
5). Kidneys were examined at various intervals after the injection
using light microscopy (LM) and immuno-fluorescence microscopy(IF). Protein excretion was measured daily during the observation
period (14 days). Administration of MoAb ER4 resulted in acute
glomerulonephritis, characterized by influx of polymorphs after two hr,
adhesions of glomerular tuft, increasing mesangial proliferation and
thickening of Bowman's capsule. Proteinuria increased rapidly from
day I and ranged between 100 to 400 mg/24 hr within the first week, and
subsequently decreased over the next period. In contrast, no protein-
uria or LM alterations were seen following administration of MoAb
ER14. Using IF, mouse IgG could be detected along the capillary walls
and in the mesangium of kidneys from rats injected with either ER4 or
ERI4, whereas glomerular depositions of complement and fibrin could
only be seen in rats treated with ER4. From these data, it is likely that
the inflammatory response was due to the complement activating
property of the subclass of MoAb ER4 since mouse IgGI (ER14), in
contrast to IgG2a, was unable to bind complement. Since both poly-
clonal ARTS and monoclonal anti-thymocyte IgG have been shown to
localize in situ in normal rat kidney after intrarenal perfusion, the
present data support the notion that T cell—like epitopes are present in
rat glomeruli, and, secondly, that binding of heterologous anti-T cell
antibodies to these epitopes in the rat kidney may be harmful for the
kidney in this experimental model depending on the IgG subclass of the
antibody involved.
Renal response to moderate sodium restriction in hypertension: effects
of ACE-inhibition. NA VIS GJ, DEJONG PE, DONKER AJM, VANDER HEM
GK, and DE ZEEUW D. Department of Nephrology, University Hospi-
tal Groningen, and Department of Medicine, Free University Hospital,
Amsterdam, The Netherlands. Severe restriction of dietary sodium (<
1 g NaClI24 hr) induces a fall in GFR. In antihypertensive treatment,
only moderate sodium restriction is practicable, but not always effec-
tive. It has been suggested that All—mediated renal mechanisms limit
the efficacy of such a sodium restriction. We therefore studied renal
hemodynamics and sodium handling in nine essential hypertensives in
balance on a liberal (200 mmole Na/24 hr) and on a moderately
restricted (50 mmole Na124 hr) sodium diet, before and during
ACE—inhibition (enalapril 10 mg bid for eight days) in a crossover
study. Results (means sEM):
200 Na 50 Na
MAP (mmHg)
GFR (mliter/minll.73 m2)
ERPF (mliter/min/l.73 m2)
109 2 110 2
111 4 104 4*
431 22 415 27
Filtered Na (mmole/min)
Tubular Na reabsorption (%)
16.9 0.7 15.5 0.6*
99.17 0.06 99.78 0.03*
Enalapril
200 Na 50 Na
MAP (mmHg)
GFR (mliter/minll.73 m2)
ERPF (mliter/minll .73 m)
98 2° 94 2°
112 4 110 4°
465 25° 473 30°
Filtered Na (mmole/min)
Tubular Na reabsorption (%)
16.7 0.6 16.4 0.6°
99.08 0.08 99.78 0.03*
Symbols are: * P < 0.02, paired test versus value on liberal sodium:
° P < 0.02, paired test versus initial value. Thus, GFR and filtered load
of Na were significantly lower on restricted sodium. GFR increased
after enalapril on low but not on liberal sodium. Consequently, the
differences in GFR and filtered load induced by sodium restriction were
no longer present after ACE-inhibition, whereas the adaption of tubular
sodium reabsorption to sodium restriction remained intact. We con-
clude that an only moderate restriction of dietary sodium, that does not
alter blood pressure, can elicit a renal hemodynamic response. This
response is abolished by ACE-inhibition. Therefore it is probably
mediated by the renin—angiotensin system. The abolition of this renal
response may contribute to the increased sodium sensitivity of blood
pressure after ACE-inhibition.
Histochemical analysis of focal segmental hyalinosis and sclerosis
(FSGHS) lesions in various rat models of experimental nephrotlc syn-
drome. GROND J, VAN GooR H, and ELEMA JD. Department of
Pathology, University of Groningen, Groningen, The Netherlands. In
the rat, glomerular lesions akin to FSGHS in humans develop during
aging (A) after reduction of renal mass, such as unilateral nephrectomy
(UN) due to hemodynamic overload of the remaining nephrons, and
secondary, to toxic glomerular damage after repeated injections with
puromycin aminonucleoside (PAN). The present study focused on the
composition of FSGHS lesions in male Wistar A, UN, and PAN rats.
All rats developed the NS with severe proteinuria and hyperlipidemia
during the experimental period of respectively 12, 7, and 4 months.
Immunofluorescence studies revealed large quantities of fibrinogen and
smaller amounts of 1gM and C3 in the FSGHS lesions, and no significant
differences between sclerotic glomeruli of A, UN and PAN rats were
noted. Massive depositions of lipids, stained with the Oil-Red-O
method on frozen sections, were invariably present in FSGHS lesions
of all rats. These lipid deposits were shown to consist mainly of free
cholesterol, stained with a histochemical oxidase method, and of
esterified cholesterol, demonstrated as cholesterol after hydrolysis by
cholesterol ester hydrolase. Triglycerides, stained by a lipase technique
after extraction of free fatty acids by a potassium hydroxide—dioxan
mixture, were present in much lower amounts. The lipid composition of
the lesions was similar in A, UN and PAN rats. In the UN and PAN
group (A rats not done), serum cholesterol levels correlated signifi-
cantly with the percentage of glomerular cholesterol deposits and
FSGHS (respectively r = 0.71, N = 19; r = 0.74, N = 14, P < 0.01)
suggesting that the glomerular cholesterol accumulations in FSGHS in
these models are, at least partly, derived from serum lipoproteins.
Non-specific esterase activity using alpha.naphtyl butyrate as sub-
strate, revealed the presence of a few monocytes/macrophages in
FSGHS lesions, and the A, UN and PAN rats did not differ in this
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respect either. In conclusion, FSGHS lesions in A, UN and PAN rats lipids—primarily cholesterol and cholesteryl ester—, and macrophages
harbour macromolecular substances of comparable composition. More- strikingly resembles the lesion of atherosclerosis. This may indicate a
over, the segmental glomerular accumulation of serum proteins, parallel pathogenesis,
